Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA: Apple De Novo Approvals Signal Innovation To Digital Health Firms

Executive Summary

The latest Apple Watch includes an electrocardiogram that has received de novo clearance from US FDA to detect irregular heart rhythms. The approval, say two top US FDA regulators, is a signal to the digital health industry that the agency is trying to help them innovate.


Related Content

Medtech’s AI Pioneers – Where Are We Headed?
FDA Explains Why It Approved Apple Watch's De Novo Despite Missing Primary Endpoint
Rise Of The Machines: FDA Artificial Intelligence Guidance Is Coming
ACC Results Recap Part I: Low-Risk TAVR Trials Bring Good News For Edwards And Medtronic; Apple Watch Detects AFib In Apple Heart Study
Scott Gottlieb Calls It Quits After An Active Tenure At US FDA
Market Intel: Digital Tech At The Heart Of Cardiology Innovation
US FDA Commish Defends Approach To Apple Approvals
Size Doesn't Matter: US FDA Refines Dig-Health Pre-Cert Model
FDA Readies Digital Health Pre-Cert Program For Lift Off
AliveCor Shows Off Apple Watch EKG Play, Launches Upgrades


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts